期刊文献+

毛蕊花糖苷在常氧、缺氧大鼠体内药动学的比较

In vivo pharmacokinetic comparison of verbascoside in normoxic and hypoxic rats
下载PDF
导出
摘要 目的比较毛蕊花糖苷在常氧、缺氧大鼠体内药动学。方法采用低压低氧动物实验舱模拟高原环境制备急性缺氧大鼠模型,常氧、缺氧大鼠灌胃给予毛蕊花糖苷(300 mg/kg),于5、10、15、30、45 min及1、1.5、2、4、6、8、12、24 h采血,HPLC-QTOF-MS法检测毛蕊花糖苷、羟基酪醇、咖啡酸血药浓度,计算主要药动学参数。结果常氧、缺氧大鼠血浆中均未检测到羟基酪醇。与常氧大鼠血浆比较,缺氧大鼠血浆中毛蕊花糖苷AUC_(0~)_(t)、AUC_(0~∞)、C_(max)降低(P<0.05),T_(max)、V_(z)/F升高(P<0.05);咖啡酸AUC_(0~)_(t)、AUC_(0~∞)、C_(max)降低(P<0.05),MRT_(0~∞)、T_(max)、V_(z)/F升高(P<0.05)。结论在缺氧条件下,毛蕊花糖苷及其活性代谢产物咖啡酸的药动学参数发生明显变化。 AIM To compare the in vivo pharmacokinetics of verbascoside in normoxic and hypoxic rats.METHODS The acute hypoxic rat model was established by simulating high-altitude environment in hypobaric hypoxia animal experimental chamber.Normoxic and hypoxic rats were given intragastric administration of verbascoside(300 mg/kg),after which blood collection was made at 5,10,15,30,45 min and 1,1.5,2,4,6,8,12,24 h.HPLC-QTOF-MS was adopted in the plasma concentration determination of verbascoside,hydroxytyrosol and caffeic acid,and main pharmacokinetic parameters were calculated.RESULTS Hydroxytyrosol was not detected in normoxia and hypoxia rat plasma.Verbascoside demonstrated decreased AUC_(0-)_(t),AUC_(0-∞),C_(max)(P<0.05) and increased T_(max),V_(z)/F(P<0.05) in hypoxia rat plasma as compared with those in normoxia rat plasma,along with decreased AUC_(0-)_(t),AUC_(0-∞),C_(max)(P<0.05) and increased MRT_(0-∞),T_(max),V_(z)/F(P<0.05) for caffeic acid.CONCLUSION Under hypoxic condition,the pharmacokinetic parameters for verbascoside and its metabolite caffeic acid exhibit obvious changes.
作者 王维刚 李晓琳 燕娜 刘天龙 王芃 郭姿良 吴迪 李茂星 WANG Wei-gang;LI Xiao-lin;YAN Na;LIU Tian-long;WANG Peng;GUO Zi-liang;WU Di;LI Mao-xing(Department of Clinical Pharmacy,The 940th Hospital of Joint Logistic Support Force of PLA,Lanzhou 730050,China;College of Pharmacy,Gansu University of Chinese Medicine,Lanzhou 730000,China;Gansu Provincial Technology Center for Plateau Pharmacy,Lanzhou 730050,China;College of Pharmacy,Lanzhou University,Lanzhou 730030,China;College of Pharmacy,Ningxia Medical University,Yinchuan 750004,China)
出处 《中成药》 CAS CSCD 北大核心 2022年第4期1041-1047,共7页 Chinese Traditional Patent Medicine
基金 中央高校基本科研业务费专项资金项目(31920200010) 青年培育项目(2021yxky060) 应急医学科研项目(20yjky018) 甘肃省重点研发项目(20YF3FA035) 甘肃省卫生行业科研项目计划(GSWSKY2020-41)。
关键词 毛蕊花糖苷 常氧 缺氧 体内药动学 HPLC-QTOF-MS verbascoside normoxia hypoxia in vivo pharmacokinetics HPLC-QTOF-MS caffeic acid hydroxytyrosol
  • 相关文献

参考文献3

二级参考文献45

  • 1杨芳艳,蒲小平.类叶升麻苷对鱼藤酮致SH-SY5Y细胞凋亡的保护作用[J].中国药理学通报,2006,22(2):159-164. 被引量:17
  • 2Mendell J, Zahir H, Matsushima N, et al. Drug - drug interaction studies of cardiovascular drugs involving P - glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor[ J]. Am J Cardiovasc Dru~.s, 2013,13:331 - 342.
  • 3Liao Q, Yang W, Chen X, et al. LC - MS determination and phar- macokinetic studies of ursolic acid in rat plasma after administration of the traditional chinese medicinal preparation Lu- Ying extract [Jl. Yakugaku Zasshi, 2005,125:509 -515.
  • 4Choi JS, Choi I, Choi DH, et al. Effects of nifedipine on the phar- macokinetics of repaglinide in rats: Possible role of CYP3A and P - glycoprotein inhibition by nifedipine [ J ]. Pharma~ol Rep, 2013, 65:1422 - 1430.
  • 5Yang C, Zhang T, Li Z, et al. P - glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: In vitro, in situ, in vivo and in silico studies [ J ]. Toxicol Appl Phar- macol, 2013,273:561 -568.
  • 6hanem CI, Arias A, Novak A, et al. Acetaminophen - induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestine cell line[ J]. Biochem Pharma~ol, 2011,81:244 - 250.
  • 7Sun BT, Zheng LH, Bao YL, et al. Reversal effect of Dioscin on muhidrug resistance in human hepatoma HepG2/adriamyein cells [ J ]. Eur J Pharmacol, 2011,654 : 129 - 134.
  • 8Tian QE, Li HD, Cai HL, et al. Astragalus polysaccharides can regulate cytokine and P - glyeoprotein expression in H22 tumor - bearing mice [ J ]. World J Gastroenterol, 2012,18:7079 - 7086.
  • 9Xiang W, Gao A, Liang H, et al. Reversal of P - glyeoprotein - mediated muhidrug resistance in vitro by milbemycin compounds in adriamyein - resistant human breast carcinoma( MCF - 7/adr) cells [J]. Toxicol In Vitro, 2010,24:1474-1481.
  • 10Mulero MC, Bigas A, Espinosa L, et al. IKBct beyond the NF - KB dogma[ J]. Oncotarget, 2013,4 : 1550 - 1551.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部